Genomma Lab Internacional SAB de CV (OTCPK:GNMLF)
$ 1.12 0.05 (4.67%) Market Cap: 1.04 Bil Enterprise Value: 1.30 Bil PE Ratio: 14.74 PB Ratio: 1.96 GF Score: 69/100

Q4 2022 Genomma Lab Internacional SAB de CV Earnings Call Transcript

Feb 23, 2023 / 04:00PM GMT
Release Date Price: $0.86 (+2.75%)
Operator

Greetings, ladies and gentlemen. Thank you for joining Genomma Lab's Fourth Quarter and Full Year 2022 Earnings Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded and will be available for replay from the Investor Relations section of Genomma's website following this call.

I'll now turn the call over to Barbara Cano of the InspIR Group. Please go ahead.

Barbara Cano

Thank you, operator. Good morning, everyone, and thank you for joining today's call. On the call are Jorge Brake, Chief Executive Officer; Marco Sparvieri, CEO designate; and Antonio Zamora, Chief Financial Officer.

Before we get started, I'd like to remind you that the remarks today will include forward-looking statements, such as the company's financial guidance and expectations, including long-term objectives and forecasts as well as expectations regarding Genomma's business, assets, products, strategies, demand and markets. These statements are subject to risks and uncertainties that could cause actual results to differ materially. They're

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot